{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T11:46:31Z","timestamp":1782819991409,"version":"3.54.5"},"reference-count":25,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Progestins are widely used for endometriosis with proven efficacy and favorable safety. Their microvascular effects, however, are not fully understood. We report a 35-year-old woman who developed recurrent hand erythema and significant nailfold videocapillaroscopy abnormalities after starting dienogest. This prompted a review of available evidence on the vascular impact of progestins, particularly dienogest. Current data indicate complex, dose-dependent effects on microcirculation. Dienogest appears to have a more favorable profile than other synthetic progestins, with limited impact on endothelial adhesion molecules and preservation of estrogen-induced vasodilation. Nonetheless, progestins can modulate endothelial proliferation, angiogenic factor expression, and vascular tone through genomic and non-genomic mechanisms. While generally safe, individual susceptibility to vascular effects may occur. Clinicians should be aware of potential microvascular manifestations during progestin therapy and consider capillaroscopy in patients presenting with relevant cutaneous changes.<\/jats:p>","DOI":"10.1515\/hmbci-2025-0029","type":"journal-article","created":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T15:59:12Z","timestamp":1779638352000},"page":"33-37","source":"Crossref","is-referenced-by-count":0,"title":["Dienogest-associated capillaroscopic abnormalities: a case report and narrative review of progestin microvascular effects"],"prefix":"10.1515","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0802-6825","authenticated-orcid":false,"given":"Angelo","family":"Nigro","sequence":"first","affiliation":[{"name":"Department of Rheumatology of Lucania\u00a0\u2013\u00a0UOSD of Rheumatology , \u201cMadonna delle Grazie\u201d Hospital , Matera , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"2026063010571584387_j_hmbci-2025-0029_ref_001","doi-asserted-by":"crossref","unstructured":"Schindler, AE. Dienogest in long-term treatment of endometriosis. Int J Womens Health 2011;3:175\u201384. https:\/\/doi.org\/10.2147\/ijwh.s5633.","DOI":"10.2147\/IJWH.S5633"},{"key":"2026063010571584387_j_hmbci-2025-0029_ref_002","doi-asserted-by":"crossref","unstructured":"Harada, T, Taniguchi, F. Dienogest: a new therapeutic agent for the treatment of endometriosis. Womens Health 2010;6:27\u201335. https:\/\/doi.org\/10.2217\/whe.09.72.","DOI":"10.2217\/WHE.09.72"},{"key":"2026063010571584387_j_hmbci-2025-0029_ref_003","doi-asserted-by":"crossref","unstructured":"Mitchell, JB, Chetty, S, Kathrada, F. Progestins in the management of endometriosis: meta-analysis. BMC Womens Health 2022;22:526. https:\/\/doi.org\/10.1186\/s12905-022-02122-0.","DOI":"10.1186\/s12905-022-02122-0"},{"key":"2026063010571584387_j_hmbci-2025-0029_ref_004","doi-asserted-by":"crossref","unstructured":"Vercellini, P, Vigan\u00f2, P, Somigliana, E, Fedele, L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol 2014;10:261\u201375. https:\/\/doi.org\/10.1038\/nrendo.2013.255.","DOI":"10.1038\/nrendo.2013.255"},{"key":"2026063010571584387_j_hmbci-2025-0029_ref_005","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Solares, J, Donnez, J, Donnez, O, Dolmans, MM. Pathogenesis of uterine adenomyosis: invagination or metaplasia? Fertil Steril 2018;109:371\u20139. https:\/\/doi.org\/10.1016\/j.fertnstert.2017.12.030.","DOI":"10.1016\/j.fertnstert.2017.12.030"},{"key":"2026063010571584387_j_hmbci-2025-0029_ref_006","doi-asserted-by":"crossref","unstructured":"Casper, RF. Progestin-only pills May be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills. Fertil Steril 2017;107:533\u20136. https:\/\/doi.org\/10.1016\/j.fertnstert.2017.01.003.","DOI":"10.1016\/j.fertnstert.2017.01.003"},{"key":"2026063010571584387_j_hmbci-2025-0029_ref_007","doi-asserted-by":"crossref","unstructured":"Petraglia, F, Hornung, D, Seitz, C, Faustmann, T, Gerlinger, C, Luisi, S, et al.. Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment. Arch Gynecol Obstet 2012;285:167\u201373. https:\/\/doi.org\/10.1007\/s00404-011-1941-7.","DOI":"10.1007\/s00404-011-1941-7"},{"key":"2026063010571584387_j_hmbci-2025-0029_ref_008","doi-asserted-by":"crossref","unstructured":"R\u00f6mer, T. Long-term treatment of endometriosis with dienogest: retrospective analysis of efficacy and safety in clinical practice. Arch Gynecol Obstet 2018;298:747\u201353. https:\/\/doi.org\/10.1007\/s00404-018-4864-8.","DOI":"10.1007\/s00404-018-4864-8"},{"key":"2026063010571584387_j_hmbci-2025-0029_ref_009","doi-asserted-by":"crossref","unstructured":"Murji, A, Bibero\u011flu, K, Leng, J, Mueller, MD, R\u00f6mer, T, Vignali, M, et al.. Use of dienogest in endometriosis: literature review and expert commentary. Curr Med Res Opin 2020;36:895\u2013907. https:\/\/doi.org\/10.1080\/03007995.2020.1744120.","DOI":"10.1080\/03007995.2020.1744120"},{"key":"2026063010571584387_j_hmbci-2025-0029_ref_010","doi-asserted-by":"crossref","unstructured":"Simoncini, T, Mannella, P, Fornari, L, Caruso, A, Varone, G, Genazzani, AR. In vitro effects of progesterone and progestins on vascular cells. Steroids 2003;68:831\u20136. https:\/\/doi.org\/10.1016\/j.steroids.2003.08.006.","DOI":"10.1016\/j.steroids.2003.08.006"},{"key":"2026063010571584387_j_hmbci-2025-0029_ref_011","doi-asserted-by":"crossref","unstructured":"Stanczyk, FZ, Archer, DF, Bhavnani, BR. Ethinyl estradiol and 17\u03b2-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment. Contraception 2013;87:706\u201327. https:\/\/doi.org\/10.1016\/j.contraception.2012.12.011.","DOI":"10.1016\/j.contraception.2012.12.011"},{"key":"2026063010571584387_j_hmbci-2025-0029_ref_012","doi-asserted-by":"crossref","unstructured":"Cutolo, M, Pizzorni, C, Secchi, ME, Sulli, A. Capillaroscopy. Best Pract Res Clin Rheumatol 2008;22:1093\u2013108. https:\/\/doi.org\/10.1016\/j.berh.2008.09.001.","DOI":"10.1016\/j.berh.2008.09.001"},{"key":"2026063010571584387_j_hmbci-2025-0029_ref_013","doi-asserted-by":"crossref","unstructured":"Lled\u00f3-Ib\u00e1\u00f1ez, GM, S\u00e1ez Comet, L, Freire Dapena, M, Mesa Navas, M, Mart\u00edn Casc\u00f3n, M, Guill\u00e9n del Castillo, A, et al.. CAPI-detect: machine learning in capillaroscopy reveals new variables influencing diagnosis. Rheumatology 2025:keaf073.","DOI":"10.1093\/rheumatology\/keaf073"},{"key":"2026063010571584387_j_hmbci-2025-0029_ref_014","doi-asserted-by":"crossref","unstructured":"Tatsumi, H, Kitawaki, J, Tanaka, K, Hosoda, T, Honjo, H. Lack of stimulatory effect of dienogest on the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by endothelial cell as compared with other synthetic progestins. Maturitas 2002;42:287\u201394. https:\/\/doi.org\/10.1016\/s0378-5122(02)00157-3.","DOI":"10.1016\/S0378-5122(02)00157-3"},{"key":"2026063010571584387_j_hmbci-2025-0029_ref_015","doi-asserted-by":"crossref","unstructured":"Henmi, N, Takahashi, K, Amita, M, Takata, K, Ohta, T, Tsutsumi, S, et al.. Effect of dienogest on estrogen-induced nitric oxide production in human umbilical vein endothelial cells and endothelium-dependent vasodilatation in postmenopausal women. Menopause 2010;17:615\u201321. https:\/\/doi.org\/10.1097\/gme.0b013e3181d273c7.","DOI":"10.1097\/gme.0b013e3181d273c7"},{"key":"2026063010571584387_j_hmbci-2025-0029_ref_016","doi-asserted-by":"crossref","unstructured":"Maeda, E, Koshiba, A, Mori, T, Ito, F, Kataoka, H, Okimura, H, et al.. Atherosclerosis-related biomarkers in women with endometriosis: the effects of dienogest and oral contraceptive therapy. Eur J Obstet Gynecol Reprod Biol 2020;7:100108. https:\/\/doi.org\/10.1016\/j.eurox.2020.100108.","DOI":"10.1016\/j.eurox.2020.100108"},{"key":"2026063010571584387_j_hmbci-2025-0029_ref_017","doi-asserted-by":"crossref","unstructured":"Vazquez, F, Rodriguez-Manzaneque, JC, Lydon, JP, Edwards, DP, O\u2019Malley, BW, Iruela-Arispe, ML. Progesterone regulates proliferation of endothelial cells. J\u00a0Biol Chem 1999;274:2185\u201392. https:\/\/doi.org\/10.1074\/jbc.274.4.2185.","DOI":"10.1074\/jbc.274.4.2185"},{"key":"2026063010571584387_j_hmbci-2025-0029_ref_018","doi-asserted-by":"crossref","unstructured":"Okada, H, Okamoto, R, Tsuzuki, T, Tsuji, S, Yasuda, K, Kanzaki, H. Progestins inhibit estradiol-induced vascular endothelial growth factor and stromal cell-derived factor 1 in human endometrial stromal cells. Fertil Steril 2011;96:786\u201391. https:\/\/doi.org\/10.1016\/j.fertnstert.2011.06.048.","DOI":"10.1016\/j.fertnstert.2011.06.048"},{"key":"2026063010571584387_j_hmbci-2025-0029_ref_019","doi-asserted-by":"crossref","unstructured":"Barbagallo, M, Dominguez, LJ, Licata, G, Shan, J, Bing, L, Karpinski, W, et al.. All vascular effects of progesterone: role of cellular calcium regulation. Hypertension 2001;37:142\u20137. https:\/\/doi.org\/10.1161\/01.hyp.37.1.142.","DOI":"10.1161\/01.HYP.37.1.142"},{"key":"2026063010571584387_j_hmbci-2025-0029_ref_020","doi-asserted-by":"crossref","unstructured":"White, MM, Zamudio, S, Stevens, T, Tyler, R, Lindenfeld, J, Leslie, K, et al.. Estrogen, progesterone, and vascular reactivity: potential cellular mechanisms. Endocr Rev 1995;16:739\u201351. https:\/\/doi.org\/10.1210\/edrv-16-6-739.","DOI":"10.1210\/edrv-16-6-739"},{"key":"2026063010571584387_j_hmbci-2025-0029_ref_021","doi-asserted-by":"crossref","unstructured":"Zheng, S, Huang, J, Zhou, K, Xiang, Q, Zhang, J, Tan, Z, et al.. Progesterone enhances vascular endothelial cell migration via activation of focal adhesion kinase. J\u00a0Cell Mol Med 2012;16:296\u2013305. https:\/\/doi.org\/10.1111\/j.1582-4934.2011.01305.x.","DOI":"10.1111\/j.1582-4934.2011.01305.x"},{"key":"2026063010571584387_j_hmbci-2025-0029_ref_022","doi-asserted-by":"crossref","unstructured":"Simoncini, T, Caruso, A, Garibaldi, S, Fu, XD, Giretti, MS, Baldacci, C, et al.. Activation of nitric oxide synthesis in human endothelial cells using nomegestrol acetate. Obstet Gynecol 2006;108:969\u201378. https:\/\/doi.org\/10.1097\/01.aog.0000233184.64531.84.","DOI":"10.1097\/01.AOG.0000233184.64531.84"},{"key":"2026063010571584387_j_hmbci-2025-0029_ref_023","doi-asserted-by":"crossref","unstructured":"Stanczyk, FZ, Hapgood, JP, Winer, S, Mishell, DRJr. Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects. Endocr Rev 2013;34:171\u2013208. https:\/\/doi.org\/10.1210\/er.2012-1008.","DOI":"10.1210\/er.2012-1008"},{"key":"2026063010571584387_j_hmbci-2025-0029_ref_024","doi-asserted-by":"crossref","unstructured":"Piacenti, I, Tius, V, Viscardi, MF, Biasioli, A, Arcieri, M, Restaino, S, et al.. Dienogest vs. combined oral contraceptive: a systematic review and meta-analysis of efficacy and side effects to inform evidence-based guidelines. Acta Obstet Gynecol Scand 2025;104:1424\u201332. https:\/\/doi.org\/10.1111\/aogs.15145.","DOI":"10.1111\/aogs.15145"},{"key":"2026063010571584387_j_hmbci-2025-0029_ref_025","doi-asserted-by":"crossref","unstructured":"Nigro, A. Temporal dissociation between clinical remission and microvascular improvement assessed by AI-assisted capillaroscopy in anti-Mi-2 dermatomyositis: potential therapeutic implications. Arthritis Rheumatol 2026. https:\/\/doi.org\/10.1002\/art.70109. Online ahead of print.","DOI":"10.1002\/art.70109"}],"container-title":["Hormone Molecular Biology and Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2025-0029\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2025-0029\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T11:04:22Z","timestamp":1782817462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2025-0029\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,5,26]]},"published-print":{"date-parts":[[2026,6,24]]}},"alternative-id":["10.1515\/hmbci-2025-0029"],"URL":"https:\/\/doi.org\/10.1515\/hmbci-2025-0029","relation":{},"ISSN":["1868-1883","1868-1891"],"issn-type":[{"value":"1868-1883","type":"print"},{"value":"1868-1891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]}}}